| Metric | შპს დენკ ფარმა კავკასია | შპს თბილისი მედიკ | შპს ნიუ ფარმა | შპს ჰუმან დიაგნოსტიკ ჯორჯია | შპს ივერმედი |
|---|---|---|---|---|---|
| Growth | |||||
| Revenue | ₾22.1m₾20.5m | ₾14.8m₾14.3m | ₾14.6m₾21.9m | ₾13.1m₾12.3m | ₾45.9m₾47.1m |
| Revenue growth | 7.7% | 3.5% | -33.2% | 6.6% | -2.5% |
| Profitability | |||||
| EBITDA | ₾2.4m₾833k | ₾827k₾1.8m | -₾27k₾3.5m | ₾1.5m₾1.7m | -₾1.1m₾3.1m |
| EBITDA margin | 10.7%4.1% | 5.6%12.3% | -0.2%15.8% | 11.8%13.7% | -2.4%6.6% |
| Net profit | ₾1.4m₾589k | -₾2.2m₾1.9m | -₾1.2m₾2.1m | ₾750k₾1.1m | -₾993k₾4.4m |
| Net margin | 6.4%2.9% | -14.8%13.2% | -8.4%9.7% | 5.7%9.3% | -2.2%9.3% |
| Balance sheet | |||||
| Total assets | ₾13.2m₾11.6m | ₾18.7m₾19.7m | ₾9.7m₾10.9m | ₾17.9m₾18.0m | ₾38.9m₾42.4m |
| Total equity | ₾4.6m₾4.7m | ₾14.2m₾16.3m | ₾3.4m₾5.9m | ₾15.3m₾15.5m | ₾30.8m₾35.6m |
| ROE | 30.4%12.5% | -15.5%11.6% | -35.4%36.1% | 4.9%7.4% | -3.2%12.3% |